. 2009 Dec 30;298(3):F771–F778. doi: 10.1152/ajprenal.00266.2009

Table 6.

Parameters of bladder activity in transurethral CMGs after serial administration of vehicle, 8-OH-DPAT, and WAY-100635 in urethane-anesthetized rats

	VT, ml	Base, cmH₂O	CA, cmH₂O	CD, min	ICI, min
Vehicle (n = 12)	0.80 ± 0.29	14.77 ± 1.95	50.94 ± 5.70	0.62 ± 0.15	0.81 ± 0.20
Agonist (8-OH-DPAT; 0.3 mg/kg)	0.33 ± 0.10^*	14.99 ± 3.73	58.03 ± 7.56^*	0.66 ± 0.23	0.68 ± 0.19
Antagonist (WAY-100635; 0.1 mg/kg)	1.26 ± 0.31^*^†	14.10 ± 2.68	42.86 ± 3.15^*^†	0.65 ± 0.20	1.02 ± 0.16^*^†

Values are means ± SE. Base: basal pressure; ICI: intercontraction interval.

P < 0.05 indicates a statistically significant difference compared with vehicle treatment (post hoc least significance difference test).

^†

P < 0.05 indicates a statistically significant difference compared with 8-OH-DPAT treatment (post hoc least significance difference test).